SOR007
As of the edition of 20 October 2026, SOR007 is a drug known only by a code name: went quiet in 2020; acts on TUBA1A, TUBA1B and TUBA1C and 12 more.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Went quiet, 2020
- Kind
- Code name only
- Registered trials
- 4, 1 stopped early
- Disease areas
- Cancer; Pregnancy and women's health; Skin and connective tissue; Urinary and reproductive
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Companies that need a new molecule because of this drug
30 company-target rows on route A because of this drug.
Companies on route A for this drug
In the product30 company-target rows are on route A because of SOR007.
See the 30 company-target rows on route A for this drug, with the facts behind eachRequest access. Nothing is shown until you do.
Targets
| Gene | Protein | UniProt |
|---|---|---|
| TUBB4A | Tubulin beta-4A chain | P04350 |
| TUBB | Tubulin beta chain | P07437 |
| TUBA3C | Tubulin alpha-3C chain | P0DPH7 |
| TUBA1B | Tubulin alpha-1B chain | P68363 |
| TUBA4A | Tubulin alpha-4A chain | P68366 |
| TUBB4B | Tubulin beta-4B chain | P68371 |
| TUBB3 | Tubulin beta-3 chain | Q13509 |
| TUBB2A | Tubulin beta-2A chain | Q13885 |
| TUBB8 | Tubulin beta-8 chain | Q3ZCM7 |
| TUBA3E | Tubulin alpha-3E chain | Q6PEY2 |
| TUBA1A | Tubulin alpha-1A chain | Q71U36 |
| TUBA1C | Tubulin alpha-1C chain | Q9BQE3 |
| TUBB6 | Tubulin beta-6 chain | Q9BUF5 |
| TUBB2B | Tubulin beta-2B chain | Q9BVA1 |
| TUBB1 | Tubulin beta-1 chain | Q9H4B7 |
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 1 | 1 | 1 | 0 | 0 |
| Phase 2 | 3 | 2 | 0 | 1 |
| All trials | 4 |